The implications of a growing evidence base for drug use in elderly patients. Part 1. Statins for primary and secondary cardiovascular prevention

AA Mangoni, SHD Jackson - British journal of clinical …, 2006 - Wiley Online Library
… is good evidence that statins effectively reduce cardiovascular risk in elderly patients ≤ 80
… -lowering therapy in elderly patients with established ischaemic heart disease [26]. The ATP …

Definition and issue of medications underuse in frail elderly patients

A Piau, C Hein, F Nourhashemi, M Sebbagh… - Geriatrie et psychologie …, 2012 - jle.com
… Mangoni AA, Jackson SH The implications of a growing evidence base for drug use in
elderly patients. Part 3. Beta-adrenoceptor blockers in heart failure and thrombolytics in acute …

Reducing the global burden of cardiovascular disease, part 1: the epidemiology and risk factors

P Joseph, D Leong, M McKee, SS Anand… - … research, 2017 - Am Heart Assoc
… death certificates, especially among older people who experience multiple conditions (eg, …
second-hand smoke. There is also growing evidence of adverse effects on the cardiovascular

[HTML][HTML] Hyperlipidemias in elderly patients: results from the Berlin Aging Study II (BASEII), a cross-sectional study

A Rosada, U Kassner, F Weidemann, M König… - Lipids in Health and …, 2020 - Springer
… have seen substantially growing evidence of their causative … of the elderly group belong to
a statin benefit group, while 1% … , show effects after two years of treatment in elderly patients

Is progressive osteoarthritis an atheromatous vascular disease?

PG Conaghan, H Vanharanta… - Annals of the rheumatic …, 2005 - ard.bmj.com
Growing evidence from epidemiological studies suggests that osteoarthritis (OA) is linked to
atheromatous vascular … , and trials of the effects of statins on the prevention and treatment of …

Statins for secondary prevention in elderly patients: a hierarchical bayesian meta-analysis

J Afilalo, G Duque, R Steele, JW Jukema… - Journal of the American …, 2008 - jacc.org
primary objective of this meta-analysis was to determine whether statins reduce all-cause
mortality in elderly patients with CHD and to quantify the magnitude of the treatment effect. The …

Omission de traitement chez la personne âgée: quelle définition pour quels enjeux?

A Piau, C Hein, F Nourhashemi, M Sebbagh… - Gériatrie et Psychologie …, 2012 - jle.com
… Mangoni AA, Jackson SH The implications of a growing evidence base for drug use in
elderly patients. Part 3. Beta-adrenoceptor blockers in heart failure and thrombolytics in acute …

Recent developments in secondary prevention and cardiac rehabilitation after acute myocardial infarction

H Dalal, PH Evans, JL Campbell - BMJ, 2004 - bmj.com
Growing evidence shows suboptimal application of … perceived lack of evidence for use of
statins in older patients or other … patients and are concerned about the resource implications of …

Prescribing for older people

JC Milton, I Hill-Smith, SHD Jackson - Bmj, 2008 - bmj.com
… of angiotensin converting enzyme inhibitors and β blockers in left ventricular systolic dysfunction,
statins in … The implications of a growing evidence base for drug use in elderly patients. …

Suboptimal statin adherence and discontinuation in primary and secondary prevention populations: should we target patients with the most to gain?

JJ Ellis, SR Erickson, JG Stevenson… - Journal of general …, 2004 - Springer
primary or secondary, but not both, prevention populations.While recent studies have reported
differences in statin adherence rates among elderly patients at … effect on both prevention